The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Background: Clinical trials do not represent community settings,making widespread implementation of evidence-based medicineproblematic. New heart failure treatments are an example, asresults ...

Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol deviations or delays in data entry. Importantly, these risks can be flagged ...

SEER-Medicare data show just 4% of older adults with blood cancers enter clinical trials, revealing disparities and fixable ...

What’s the Difference Between Nontherapeutic and Therapeutic? Benefits of Nontherapeutic Clinical Trials Examples of Nontherapeutic Clinical Trials How to Find a Nontherapeutic Clinical Trial When you ...

The randomized clinical trial (RCT) is the gold standard for definitive evaluation of new therapies. RCTs designed to show that the therapeutic efficacy of a new therapy is not unacceptably inferior ...

Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks The purpose of this article is to ...

Multiplicity, or the use of many comparisons in a clinical trial, increases the likelihood that a chance association could be deemed causal. This problem commonly arises in clinical trials that have ...